Sharepoint Solutions
PRODUCTS
-
In today’s competitive and capital-constrained cell and gene therapy environment, early decisions around Chemistry, Manufacturing, and Controls (CMC) can make or break a therapy's timeline, cost-efficiency, and eventual approval. Yet many emerging cell therapy companies struggle with CMC strategy until it becomes a bottleneck.
-
Accelerate your drug development with our comprehensive pre-formulation, formulation, and novel delivery system expertise, tailored to optimize physical form, enhance solubility, and support scale-up.
-
Reduce microbiological organisms on equipment, in transfer chambers, in filling line isolators and more with Ecolab’s Bioquell IG-2, a robust, fixed bio-decontamination system.
-
We provide science-first solutions for challenging molecules, specializing in particle engineering, bioavailability, and GMP manufacturing across Bend, OR; Clearwater, FL; and Gainesville, GA.
-
Automate data acquisition, monitor trends in real time, and respond to deviations proactively.
WHITE PAPERS AND CASE STUDIES
-
Manufacturing Transfers: Delivering 140+ Precision Medical Devices Without Missing A Deadline
Go inside a successful manufacturing transfer of over 140 Class-III silicone medical devices and on-time delivery for a top-30 OEM through expert project management and rigorous validation processes.
-
Streamline AAV-Based Gene Therapies With Off-The-Shelf Plasmids
Standardized, well-characterized plasmids and streamlined platform processes can significantly accelerate viral vector development, improve consistency, and support scalable, high-quality gene therapy manufacturing.
-
Customer Story: Emergent BioSolutions Enhances Aseptic Filling Process
Upgrading outdated filling systems is essential for meeting future production demands and regulatory standards. Learn how one manufacturer modernized its approach to ensure compliance and efficiency.
-
How Adaptive Design Accelerates Early‑Phase NSCLC Development
Adaptive trial designs and an adaptive mindset enable non-small cell lung cancer (NSCLC) sponsors to optimize dose, respond to evolving expectations, and accelerate early‑phase development.
-
Accelerating SARS-CoV-2 Immunotherapy Speed To Clinic
A clinical-stage biotherapeutics company developing a COVID-19 immunotherapy searched for a solution to the difficulties it faced in scaling up its manufacturing operations due to limited resources.
-
Quantitation Of Monoclonal Antibodies In Serum
Monoclonal antibodies (mAbs) are a rapidly growing group of targeted therapeutics. Gain insight into the importance of optimized bioanalytical assay platforms for mAb development.
-
Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study
Explore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO.
-
Digital Standardization: Accelerating Gene Therapy Tech Transfer With Confidence And Compliance
Fragmented, manual data practices slow tech transfer and increase risk; centralized digital CMC systems standardize workflows, improve transparency, and accelerate onboarding while maintaining compliance.
-
Incorrect Clinical Trial Enrollment Is Preventable. A Tale Of Three Case Studies
See how three clinical trials used centralized eligibility review to accelerate enrollment, eliminate enrollment-based protocol deviations, and keep studies on track, even at a global scale.
-
How A Global Biosimilars Company Cut Manual Data Errors By 50%
Learn how a global biopharmaceutical leader halved transcription errors and integrated over 350 instruments to accelerate the development of high-quality, clinically proven biosimilars.
-
Annex 1: Sterile Fill/Finish For Early Phase Clinical Supplies
Meeting stringent requirements for sterile fill/finish operations hinges on robust contamination control strategies, advanced isolator technology, and rigorous integrity testing to ensure patient safety.
-
The Digital Transformation Of A Leading CDMO's Process Development Lab
Discover how a leading CDMO was able to create a data model for its bioreactors, resulting in easily contextualized data, time savings in manual tasks, and the ability to share insights in real time.
NEWS
-
Energy Department Slashes 47 Burdensome And Costly Regulations, Delivering First Milestone In America's Biggest Deregulatory Effort5/12/2025
The U.S. Department of Energy (DOE) today announced the first step in the Energy Department’s largest deregulatory effort in history, proposing the elimination or reduction of 47 regulations that are driving up costs and lowering quality of life for the American people.
-
Klarna Announces Partnership With OnePay To Exclusively Power Installment Loans At Walmart In The U.S3/17/2025
Klarna, the AI-powered payments and commerce network, today announced that it will be partnering with OnePay, a leading consumer finance app, to exclusively offer installment loans for purchases at Walmart in the United States.
-
Kruger Products Inaugurates New LDC Plant In Sherbrooke6/9/2025
Kruger Products Inc. today inaugurated its new LDC (light dry crepe) tissue plant in Sherbrooke, constructed on a site adjacent to its TAD plant.
-
MapleTech Introduces Aspire Quick Start2/10/2026
Maple Technologies (MapleTech), developer of the Aspire suite, a platform of integrated modules for processing personal and commercial Property & Casualty insurance, announces the availability of Quick Start, a step-by-step workflow embedded in the Aspire underwriting platform that automates trucking insurance risk intake.
-
Advancing Regional Polio Vaccine Production With Fixed-Bed Bioreactor Technology4/9/2025
Batavia Biosciences, a leading contract development and manufacturing organization (CDMO), has pioneered a novel upstream bioprocessing method to enhance regional polio vaccine production.